Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

Delayed Quote. Delayed  - 08/25 10:02:02 pm
183.3 USD   -3.04%
08/23 MCKESSON CORPOR : To Present at the Morgan Stanley Global Healthcare..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/19/2016 08/22/2016 08/23/2016 08/24/2016 08/25/2016 Date
193.85(c) 193.65(c) 192.75(c) 189.05(c) 183.3(c) Last
801 089 821 885 1 048 484 1 536 240 2 898 217 Volume
-0.30% -0.10% -0.46% -1.92% -3.04% Change
More quotes
Financials ($)
Sales 2017 204 374 M
EBIT 2017 4 685 M
Net income 2017 2 593 M
Debt 2017 3 760 M
Yield 2017 0,62%
Sales 2018 208 818 M
EBIT 2018 4 894 M
Net income 2018 2 866 M
Debt 2018 1 180 M
Yield 2018 0,66%
P/E ratio 2017 15,88
P/E ratio 2018 14,57
EV / Sales2017 0,22x
EV / Sales2018 0,20x
Capitalization 41 371 M
More Financials
Company
McKesson Corp. is a health services and information technology company, which provides medicines, pharmaceutical and care management products.It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions.The McKesson Distribution Solutions segment distributes... 
Sector
Drug Retailers
Calendar
08/30Ex-dividend day
More about the company
Surperformance© ratings of McKesson Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on MCKESSON CORPORATION
08/23 MCKESSON CORPORATION : To Present at the Morgan Stanley Global Healthcare Confer..
More news
Sector news : Drug Retailers - NEC
08/22DJSINOPHARM GROUP : 1st Half Net Profit CNY2.53 Billion, Up 32% on Year
08/17DJTarget Dims Outlook as Sales Struggle
08/09DJValeant Posts a Loss and Says It Will Retool
08/05DJAbbVie Sues Amgen Over Humira
08/02DJCVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies
More sector news : Drug Retailers - NEC
News from SeekingAlpha
08/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2016 Updat..
08/23 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2016 Upda..
08/22 Why I Didn't Buy Gilead, Apple Or 100 Others, Y'all - Part 3
08/15 NIKE & STARBUCKS : That's What I Bought, Y'all - Part 2
08/12 DIPLOMAT PHARMACY : The Correction Seems Overdone, Overlooking The Performance
Advertisement
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 208 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
James A. Beer Chief Financial Officer & Executive Vice President
Kathleen D. McElligott EVP, Chief Technology & Information Officer
Wayne A. Budd Independent Director
Alton Fernando Irby Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION-7.06%42 669
CVS HEALTH CORP-4.08%103 604
WALGREENS BOOTS ALLIAN..-5.84%88 176
EXPRESS SCRIPTS HOLDIN..-17.93%48 111
CARDINAL HEALTH INC-11.10%25 831
AMERISOURCEBERGEN CORP..-17.55%18 980
More Results